New drug aims to boost red blood cells in MDS patients
NCT ID NCT04419649
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a drug called elritercept (KER-050) in 160 adults with a bone marrow condition called myelodysplastic syndromes (MDS) who have anemia. The main goals are to check the drug's safety and how well people tolerate different doses. Researchers will also see if it helps the body make more healthy red blood cells and reduces the need for transfusions.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- elritercept (also called KER-050 or TAK-226)
- What this could lead to
- If successful, this could lead to a new treatment option for anemia in people with lower-risk MDS, potentially reducing the need for blood transfusions.
- What could go wrong
- This is an early-phase trial with only 160 participants, so results may not apply to everyone. The drug may cause side effects or fail to improve anemia significantly.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC MYELOMONOCYTIC LEUKEMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
Locations
-
Austin Health
RECRUITINGHeidelberg, Victoria, 3084, Australia
-
Ballarat Oncology & Haematology Service
COMPLETEDWendouree, Victoria, 3355, Australia
-
Border Medical Oncology Research
RECRUITINGAlbury, New South Wales, 2640, Australia
-
Boxhill Hospital
RECRUITINGBox Hill, Victoria, 3128, Australia
-
CH Rene-Dubos
RECRUITINGPontoise, France
-
CHU Angers - Hopital Hotel Dieu
COMPLETEDAngers, France
-
CHU Nice - Hopital de l'Archet 1
RECRUITINGNice, France
-
CHU de Bordeaux - Hopital Haut-Leveque
RECRUITINGTalence, France
-
CHU de Nantes - Hotel Dieu
RECRUITINGNantes, France
-
Centre Hospitalier de la Region dAnnecy
COMPLETEDÉpagny, France
-
Charite-Campus Benjamin Franklin
NOT_YET_RECRUITINGBerlin, Germany
-
City of Hope National Medical Center
RECRUITINGDuarte, California, 91010, United States
-
Fakultni nemocnice Brno
COMPLETEDBrno, Czechia
-
Fakultni nemocnice Kralovske Vinohrady
RECRUITINGPrague, Czechia
-
Flinders Medical Centre
RECRUITINGBedford Park, South Australia, 5042, Australia
-
H. Lee Moffitt Cancer Center and Research Center
RECRUITINGTampa, Florida, 33612, United States
-
Hopital Saint-Louis
RECRUITINGParis, France
-
Hospital Universitari i Politecnic La Fe
RECRUITINGValencia, Spain
-
Hospital Universitario Central de Asturias
RECRUITINGBarcelona, Spain
-
Hospital Universitario Vall d'Hebron
RECRUITINGBarcelona, Spain
-
Hospital Universitario Virgen del Rocio
COMPLETEDSeville, Spain
-
Hospital Universitario de Salamanca
RECRUITINGSalamanca, Spain
-
ICO l'Hospitalet - Hospital Duran i Reynals
RECRUITINGBarcelona, Spain
-
Karmanos Cancer Institute at Mclaren Greater Lansing
COMPLETEDLansing, Michigan, 48910, United States
-
Klinikum Bayreuth GmbH
RECRUITINGBayreuth, Germany
-
Klinikum Esslingen GmbH
RECRUITINGEsslingen am Neckar, Germany
-
Marien Hospital Dusseldorf GMBH
RECRUITINGDüsseldorf, Germany
-
Middlemore Hospital
COMPLETEDAuckland, 2025, New Zealand
-
Praxis am Volkspark Berlin
NOT_YET_RECRUITINGBerlin, Germany
-
Royal Adelaide Hospital
RECRUITINGAdelaide, South Australia, 5000, Australia
-
Royal Melbourne Hospital
RECRUITINGMelbourne, Victoria, 3050, Australia
-
Sheba Medical Center - Sheba Fund for Health Services and Research
RECRUITINGRamat Gan, 52621, Israel
-
Sourasky Medical Center - Infrastructure and Health Services Fund of the Tel Aviv Medical Center
COMPLETEDTel Aviv, 6423906, Israel
-
St Vincent's Hospital Melbourne
RECRUITINGMelbourne, Victoria, 3065, Australia
-
Townsville University Hospital
COMPLETEDDouglas, Queensland, 4814, Australia
-
Tweed Hospital
RECRUITINGTweed Heads, New South Wales, 2485, Australia
-
Universitaetsklinikum Duesseldorf AoeR
COMPLETEDDüsseldorf, Germany
-
Universitaetsklinikum Leipzig AoeR
COMPLETEDLeipzig, Germany
-
Universitaetsmedizin Rostock
COMPLETEDRostock, Germany
-
Universitaetsmedizin der Johannes Gutenberg-Universitaet Mainz
RECRUITINGMainz, Germany
-
University Hospital Bonn
NOT_YET_RECRUITINGBonn, Germany
-
University Hospital Geelong
RECRUITINGGeelong, Victoria, 3220, Australia
-
University Hospital Halle (Saale)
NOT_YET_RECRUITINGHalle, Germany
-
University of Miami School of Medicine Sylvester Comprehensive Cancer Center (SCCC)
RECRUITINGMiami, Florida, 33136, United States
-
University of Pittsburgh Medical Health Center
COMPLETEDPittsburgh, Pennsylvania, 15213, United States
-
Vseobecna Fakultni Nemocnice Praha
COMPLETEDPrague, Czechia
-
Westmead Hospital
RECRUITINGWestmead, New South Wales, 2145, Australia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a pill keep blood cancer at bay after a stem cell transplant?
- Could muscle loss predict blood cancer outcomes?
- Can a gentler chemo prep make stem cell transplants safer for blood cancer patients?
- Talking about the end: could guided conversations reduce futile cancer treatments?
- Can engineered immune cells outsmart Hard-to-Treat blood cancers?
- Can a Two-Drug combo tame a rare blood cancer?